Policy & Power
Two Regulators, Two Philosophies: How the FDA and EMA Shape AI-Driven Personalized Medicine
The FDA and EMA adopt divergent regulatory philosophies for AI in personalized medicine: the FDA emphasizes product safety and effectiveness, while the EMA prioritizes data privacy under GDPR. This contrast creates distinct trade-offs for innovation, patient safety, and capital allocation.
Arthur Sterling·November 5, 2026
